2-METHYL-4-CARBOMETHOXY-7-ENDO-[(TERT.-BUTYL-DIMETHYLSILYL)-OXY]-HYDROISOQUINOLINE
Compound with spectra: 1 NMR
![2-METHYL-4-CARBOMETHOXY-7-ENDO-[(TERT.-BUTYL-DIMETHYLSILYL)-OXY]-HYDROISOQUINOLINE](/api/compound/LtlBeLsJdGF.png?ph=true&h=300&w=458 "2-METHYL-4-CARBOMETHOXY-7-ENDO-[(TERT.-BUTYL-DIMETHYLSILYL)-OXY]-HYDROISOQUINOLINE")
| SpectraBase Compound ID | LtlBeLsJdGF |
|---|---|
| InChI | InChI=1S/C18H31NO3Si/c1-18(2,3)23(6,7)22-14-8-9-15-13(10-14)11-19(4)12-16(15)17(20)21-5/h8-9,12-15H,10-11H2,1-7H3 |
| InChIKey | AFEMLBUIKUNAHI-UHFFFAOYSA-N |
| Mol Weight | 337.54 g/mol |
| Molecular Formula | C18H31NO3Si |
| Exact Mass | 337.20732 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Prostaglandin F1.alpha. methyl ester t-butyldimethylsilyl ether
Prost-13-en-1-oic acid, 11,15-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7,9-dioxo-, methyl ester, (11.alpha.,13E,15S)-
Prost-13-en-1-oic acid, 11,15-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7,9-dioxo-, ethyl ester, (11.alpha.,13E,15S)-(.+-.)-
MOR-2
Bistrimethylsilyl 3,3,4,4-tetradeutero prostaglandin E2 methoxime methylester
DMIPS-ether of prostaglandin F-1.alpha.-methyl ester
Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,7,7a-tetrahydro-1-methoxy-7-(trimethylsilyl)-, methyl ester, (1.alpha.,4a.beta.,7.beta.,7a.beta.)-
(8.beta.)-8-[(tert-Butyldimethylsilyl)oxy]-des-A,B-18-[2-(methoxycarbonyl)ethyl]-20-methyl-20-pregnene
.alpha.-6-(trimethylsiloxy)-7-(2-(3-(trimethylsiloxy)-octa-1(E)-enyl)-3,5-di(trimethylsiloxy)cyclopentyl)heptanoic acid methyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Model studies probing the amino-Claisen rearrangement approach to hydroisoquinoline synthesis. Development of methods for stereocontrolled introduction of reserpine E ring type functionality | The Journal of Organic Chemistry | 1989 |